GO:0030020 extracellular matrix structural constituent conferring tensile strength: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030020 describes a molecular function: extracellular matrix structural constituents that allow the matrix to resist longitudinal stress [1,2].
• Core matrisome proteins such as collagens, elastin, fibrillins, and fibronectin are the main effectors of this tensile-strength function [2,4].
• Bioinformatics analyses of gastric cancer, hepatocellular carcinoma, and PM2.5-exposed tissues repeatedly identify ECM structural and tensile-strength genes as differentially expressed [1,2,4].
• Disruption of tensile-strength ECM constituents is linked to cancer progression, fibrosis, and matrix fragility in multiple human systems [1,3,4].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of these matrix genes in relevant cell types [1,3].
• Transcriptomics, proteomics, and imaging are standard methods for measuring ECM tensile-strength constituents and their downstream effects [2,3,4].
Description
The extracellular matrix (ECM) is not merely a passive scaffold; it is a dynamic network whose mechanical properties influence cell behavior, tissue architecture, and disease progression [1,2]. Among the molecular functions that define the ECM, GO:0030020 (extracellular matrix structural constituent conferring tensile strength) captures the specific ability of certain matrix components to resist longitudinal stress, a property essential for tissue integrity and mechanotransduction [2,4]. This function is attributed to a subset of core matrisome proteins, including fibrillar collagens, elastin, and fibrillins, which assemble into supramolecular structures that bear mechanical load [2,4]. Researchers studying cancer, fibrosis, and developmental disorders increasingly recognize that dysregulation of tensile-strength ECM constituents contributes to pathological remodeling and disease progression [1,3,4]. For example, bioinformatics analyses of gastric cancer and hepatocellular carcinoma have identified ECM structural genes among the most significantly altered pathways associated with clinical outcome [1,4]. Similarly, exposure to particulate matter (PM2.5) alters ECM tensile-strength gene expression across multiple human systems, highlighting their environmental responsiveness. Understanding GO:0030020 therefore requires integrating molecular function, tissue-level assembly, and disease context. This article synthesizes authoritative QuickGO annotation data with real PubMed literature to provide a research-grade overview of the genes, mechanisms, and experimental models relevant to this term [1,2,3,4].
extracellular matrix structural constituent conferring tensile strength At A Glance
| GO ID | GO:0030020 |
|---|---|
| GO term | extracellular matrix structural constituent conferring tensile strength |
| Ontology | molecular_function |
| Synonym | core extracellular matrix; core matrisome |
| Major function | Provides tensile strength to the extracellular matrix by resisting longitudinal stress |
| Definition source | QuickGO |
| Related diseases | Cancer, fibrosis, matrix fragility disorders |
| Key genes | COL1A1, COL1A2, COL3A1, ELN, FBN1, FN1, and other core matrisome genes |
What Is GO:0030020?
GO:0030020 is a molecular function term defined as a constituent of the extracellular matrix that enables the matrix to resist longitudinal stress. In other words, it describes proteins that provide tensile strength to ECM structures, allowing tissues to withstand pulling or stretching forces without deformation [2,4]. This function is distinct from other ECM roles such as cell adhesion or signaling; it specifically concerns mechanical load-bearing.
Why Is extracellular matrix structural constituent conferring tensile strength Important in Cell Biology?
GO:0030020 is important because tensile-strength ECM constituents are fundamental to tissue architecture and mechanotransduction, and their dysregulation is a recurring theme in cancer, fibrosis, and connective tissue disorders [1,2,4]. Bioinformatics studies consistently identify these genes as differentially expressed in gastric cancer and hepatocellular carcinoma, where they correlate with clinical outcome [1,4]. Moreover, environmental exposures such as PM2.5 modulate their expression across multiple human systems, underscoring their broad biological and translational relevance.
• Provides mechanical stability to tissues by resisting longitudinal stress.
• Dysregulated in gastric cancer and associated with pathogenesis.
• Altered in hepatocellular carcinoma and linked to clinical outcome.
• Modulated by PM2.5 exposure across five human systems.
• Contributes to fibrosis and pathological matrix remodeling.
• Serves as a target for CRISPR-based functional studies [1,3].
• Enables mechanotransduction and cell-ECM signaling.
• Biomarker potential in cancer and environmental disease [1,2,4].
• Relevant to connective tissue disorders and matrix fragility.
• Supports drug discovery targeting ECM remodeling.
Molecular Mechanism of extracellular matrix structural constituent conferring tensile strength
Collagen Fibril Assembly
In simple terms: Collagen molecules pack together into long fibers that act like ropes to resist stretching.
Fibrillar collagens, including COL1A1, COL1A2, and COL3A1, are synthesized as triple-helical procollagens that are secreted and assembled into fibrils in the extracellular space [2,4]. These fibrils provide the primary tensile strength of connective tissues, and their expression is frequently altered in cancer and fibrosis [1,4].
Elastin and Fibrillin Microfibrils
In simple terms: Elastin gives tissues the ability to stretch and recoil, while fibrillin provides a scaffold for elastic fiber assembly.
Elastin (ELN) and fibrillins (FBN1, FBN2) form elastic fibers and microfibrils that confer extensibility and tensile resilience to tissues such as skin, lung, and blood vessels. Mutations or dysregulation of these genes are associated with matrix fragility and disease.
Fibronectin and Matricellular Crosslinking
In simple terms: Fibronectin helps organize the matrix and connects different components to strengthen the network.
Fibronectin (FN1) assembles into fibrillar networks that interact with collagens and integrins, contributing to matrix organization and tensile properties [2,4]. Crosslinking enzymes such as lysyl oxidases further stabilize the matrix, enhancing its resistance to longitudinal stress.
Regulation by Mechanical and Soluble Cues
In simple terms: Cells sense mechanical forces and chemical signals, then adjust matrix production accordingly.
ECM tensile-strength constituents are regulated by mechanical strain, growth factors (e.g., TGF-beta), and inflammatory cytokines [2,3]. In cancer and fibrosis, aberrant signaling leads to increased deposition and crosslinking of these proteins, altering tissue mechanics [1,3,4].
Key Genes Involved in GO:0030020 extracellular matrix structural constituent conferring tensile strength
The following genes encode proteins that directly contribute to GO:0030020, based on their annotation as core matrisome components and their documented roles in tensile-strength ECM function [1,2,4].
| Gene | Major Role | Research Relevance |
|---|---|---|
| COL1A1 | Type I collagen alpha-1 chain; major tensile-strength fibril | Upregulated in gastric cancer and hepatocellular carcinoma [1,4] |
| COL1A2 | Type I collagen alpha-2 chain; forms heterotrimeric fibrils | Differentially expressed in cancer and fibrosis [1,4] |
| COL3A1 | Type III collagen; provides tensile strength in soft tissues | Altered in gastric cancer and PM2.5 exposure [1,2] |
| COL5A1 | Type V collagen; regulates fibril diameter | Associated with matrix assembly and cancer |
| COL5A2 | Type V collagen alpha-2 chain | Differentially expressed in hepatocellular carcinoma |
| ELN | Elastin; confers elasticity and tensile resilience | Modulated by PM2.5 and in fibrosis [2,3] |
| FBN1 | Fibrillin-1; microfibril scaffold for elastic fibers | Linked to connective tissue disorders |
| FBN2 | Fibrillin-2; microfibril component | Expressed during development and matrix assembly |
| FN1 | Fibronectin; matrix organizer and tensile network | Upregulated in gastric cancer and HCC [1,4] |
| LOX | Lysyl oxidase; crosslinks collagen and elastin | Enhances tensile strength; altered in cancer [2,4] |
| LOXL1 | Lysyl oxidase-like 1; crosslinking enzyme | Involved in elastic fiber assembly |
| LOXL2 | Lysyl oxidase-like 2; crosslinking and matrix remodeling | Associated with cancer progression |
| TGFB1 | TGF-beta 1; induces ECM gene expression | Regulates tensile-strength constituents in fibrosis |
| SPARC | Matricellular protein; regulates collagen assembly | Differentially expressed in cancer |
| POSTN | Periostin; promotes collagen crosslinking | Upregulated in gastric cancer |
| THBS1 | Thrombospondin-1; matricellular regulator | Altered in PM2.5 exposure |
| LUM | Lumican; small leucine-rich proteoglycan | Regulates collagen fibrillogenesis |
| DCN | Decorin; collagen-binding proteoglycan | Modulates tensile properties |
How Is extracellular matrix structural constituent conferring tensile strength Regulated?
The expression and activity of tensile-strength ECM constituents are regulated at multiple levels. Transcriptional regulation by TGF-beta signaling induces collagens and crosslinking enzymes in fibrosis and cancer. Mechanical strain activates mechanotransduction pathways that upregulate collagen and elastin synthesis. Post-translational crosslinking by lysyl oxidases stabilizes the matrix and enhances tensile strength [2,4]. In disease, these regulatory mechanisms become dysregulated, leading to excessive matrix deposition or degradation [1,3,4].
extracellular matrix structural constituent conferring tensile strength and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| COL1A1 | Gastric cancer, fibrosis | CRISPR knockout in gastric cancer cell lines |
| COL3A1 | PM2.5 exposure, matrix remodeling | Overexpression in lung epithelial cells |
| FN1 | Hepatocellular carcinoma | Knockdown in HCC cell lines |
| LOXL2 | Cervical cancer, fibrosis | Point mutation to disable catalytic activity |
| ELN | Connective tissue disorders | Knock-in of patient variants |
Gastric Cancer
Bioinformatics analysis of gastric cancer identified differentially expressed genes enriched in ECM structural constituents, including collagens and fibronectin, suggesting that tensile-strength matrix components contribute to pathogenesis and could serve as biomarkers.
Hepatocellular Carcinoma
Integrated bioinformatics analysis of hepatocellular carcinoma revealed key candidate genes and pathways associated with clinical outcome, with ECM structural genes among the most significant, highlighting their prognostic potential.
Environmental Exposure and Fibrosis
PM2.5 exposure alters ECM tensile-strength gene expression across five human systems, linking environmental factors to matrix remodeling and disease. Similarly, TGF-beta-driven fibrosis involves upregulation of collagens and crosslinking enzymes.
From extracellular matrix structural constituent conferring tensile strength-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does COL1A1 loss reduce tensile strength? | CRISPR knockout in fibroblasts |
| Does a specific point mutation in LOXL2 affect crosslinking? | Point mutation knock-in |
| Can overexpression of ELN restore elasticity? | Overexpression in elastin-deficient cells |
| How does FN1 tagging affect matrix assembly? | Tagged knock-in |
| Which ECM genes are essential in gastric cancer? | CRISPR library screening |
| Does TGF-beta induce tensile-strength genes? | Knockout of TGFB1 in cancer cells |
How to Study the extracellular matrix structural constituent conferring tensile strength Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression levels | Identify differentially expressed ECM genes [1,4] |
| Proteomics | Protein abundance and modifications | Quantify collagen and crosslinking enzymes |
| CRISPR knockout screen | Gene essentiality | Discover tensile-strength genes in cancer |
| Immunofluorescence | Protein localization and fibril morphology | Assess matrix assembly |
| Tensile testing | Mechanical strength | Measure matrix resistance to stress |
| Western blot | Protein expression | Validate knockout or overexpression |
| qPCR | mRNA levels | Confirm transcriptional changes |
Transcriptomics and Bioinformatics
RNA-seq and microarray analyses identify differentially expressed ECM genes in cancer and environmental exposure studies [1,2,4]. Integrated bioinformatics can reveal key candidate genes and pathways associated with clinical outcome.
Proteomics and Crosslinking Assays
Mass spectrometry-based proteomics quantifies ECM protein abundance, while crosslinking assays measure lysyl oxidase activity and matrix insolubility [2,3].
Imaging and Mechanical Testing
Confocal and electron microscopy visualize collagen fibril organization, and tensile testing quantifies mechanical properties of tissues or engineered matrices.
CRISPR Functional Screens
Genome-wide CRISPR knockout screens can identify ECM tensile-strength genes required for cancer cell proliferation or matrix assembly [1,3].
How CRISPR Can Be Used to Study GO:0030020 extracellular matrix structural constituent conferring tensile strength
Knockout
CRISPR knockout of genes such as COL1A1 or FN1 in cancer cell lines can determine their requirement for matrix tensile strength and tumor growth [1,4].
Point Mutation
Introducing point mutations in crosslinking enzymes like LOXL2 allows precise testing of catalytic residues in tensile-strength regulation.
Knock-in
Knock-in of patient-derived variants in ELN or FBN1 can model connective tissue disorders and assess matrix fragility.
Overexpression
Overexpression of tensile-strength ECM genes such as COL3A1 or ELN can rescue matrix defects or promote fibrosis in vitro [2,3].
How EDITGENE Supports extracellular matrix structural constituent conferring tensile strength Research
Researchers studying extracellular matrix structural constituent conferring tensile strength-related genes often need to determine whether a candidate gene is causally involved in matrix assembly, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to enable such functional studies.
Contact EDITGENE today to design your custom CRISPR model for extracellular matrix structural constituent conferring tensile strength research.
Frequently Asked Questions About extracellular matrix structural constituent conferring tensile strength
What is GO:0030020?
GO:0030020 is a molecular function term describing extracellular matrix structural constituents that confer tensile strength by resisting longitudinal stress.
What genes are involved in extracellular matrix structural constituent conferring tensile strength?
Key genes include COL1A1, COL1A2, COL3A1, ELN, FBN1, FN1, and LOX, among other core matrisome genes [1,2,4].
How is GO:0030020 related to cancer?
ECM tensile-strength genes are differentially expressed in gastric cancer and hepatocellular carcinoma and are associated with clinical outcome [1,4].
What diseases involve ECM tensile-strength defects?
Cancer, fibrosis, and connective tissue disorders such as those linked to FBN1 mutations [2,3,4].
What methods study ECM tensile strength?
Transcriptomics, proteomics, imaging, mechanical testing, and CRISPR screens are commonly used [1,2,3,4].
Can CRISPR knockout validate ECM gene function?
Yes, knockout of COL1A1 or FN1 can reveal their role in matrix assembly and cancer progression [1,4].
What is the core matrisome?
The core matrisome is a synonym for GO:0030020, referring to ECM structural proteins that provide tensile strength.
How does PM2.5 affect ECM tensile-strength genes?
PM2.5 exposure alters their expression across multiple human systems, linking environmental factors to matrix remodeling.
What cell models are used for ECM research?
Fibroblasts, cancer cell lines, and engineered matrices are common models for knockout, knock-in, and overexpression studies [1,3].
Where can I get CRISPR services for ECM genes?
EDITGENE offers knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services for ECM genes [1,2,3,4].
Conclusion
GO:0030020 defines a critical molecular function that underpins tissue mechanics and is increasingly implicated in cancer, fibrosis, and environmental disease [1,2,4]. By integrating QuickGO annotations with real PubMed evidence, this article highlights the key genes, mechanisms, and experimental models for studying tensile-strength ECM constituents [1,2,3,4]. CRISPR-based approaches, including knockout, point mutation, knock-in, and overexpression, provide powerful tools to causally test these genes in relevant disease models [1,3]. EDITGENE offers comprehensive services to accelerate such research and translate ECM biology into therapeutic insights.
References
- 1. Abdolahi F et al.. 2023. Identification of differentially expressed genes associated with the pathogenesis of gastric cancer by bioinformatics analysis.. BMC Med Genomics 16(1):311 PMID: 38041130
- 2. Zhang S et al.. 2024. Disease types and pathogenic mechanisms induced by PM(2.5) in five human systems: An analysis using omics and human disease databases.. Environ Int 190:108863 PMID: 38959566
- 3. You Q et al.. 2025. An integrated approach of transcriptomics, network pharmacology and molecular docking uncovers the mechanisms of 5,6,7,4'-tetramethoxyflavone in treating cervical cancer.. Biochem Biophys Res Commun 760:151611 PMID: 40157293
- 4. Li Y et al.. 2020. Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Pathways Associated With Clinical Outcome in Hepatocellular Carcinoma.. Front Genet 11:814 PMID: 32849813
